Boston Scientific to present at Bernstein conference and report Q2 2026 results on July 29

Boston Scientific will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 27, 2026, featuring a Q&A session with CEO Mike Mahoney and CMO Janar Sathananthan. The company will also release its financial results for the second quarter ending June 30, 2026, on July 29, followed by a conference call hosted by Mahoney and CFO Jon Monson. These events provide insights into the company's performance and strategic direction in medical technology innovation.